Influenza and Adaptive Immunity
We perform research related to modulation of adaptive immune responses. Influenza is the key disease model used, and the research includes investigations into both the immunological signatures of vaccine efficacy as well as development of the next generation vaccines against infectious diseases. A challenge is that conventional vaccines fail to elicit protective immunity against highly mutagenic pathogens, or pathogens that have developed mechanisms to thwart the immune system. A main objective for the group is thus to study immunological mechanisms behind protective immunity, and development improved vaccine formats.